Stentit

The next generation in stent technology

Eindhoven · $15.5M raised

Headquarters
Eindhoven
Employees
1–10
Business Model
B2B
Total Funding
$15.5M
Last Round
$11.0M Series AJun 2023
Rounds
3

About

STENTiT is a Dutch MedTech company transforming vascular reconstruction through its Resorbable Fibrillated Scaffold (RFS), a temporary vascular support structure that triggers a natural healing response to regrow an artery from the inside out. It initially targets below-the-knee chronic limb-threatening ischemia (CLTI), a condition affecting 3.5 million patients in the EU and US, and is led by CEO and founder Bart Sanders.

Summary

Stentit is a Biotech company based in Eindhoven. It has raised $15.5M in total across 3 rounds, most recently a $11.0M Series A round in Jun 2023. Investors include European Innovation Council Fund.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AJun 2023
$11.0M

Sign up to see all 3 rounds

Seed through Grant — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Stentit on Indexed.vc
<a href="https://indexed.vc/companies/stentit"><img src="https://indexed.vc/api/badge/company/stentit" alt="Stentit on Indexed.vc" width="260" height="76" /></a>